THE TUMOR IMMUNE MICROENVIRONMENT AS A KEY DETERMINANT OF DISEASE PROGRESSION AND THERAPEUTIC RESPONSE IN HPV-ASSOCIATED CERVICAL CANCER

ORIGINAL SOURCE
Originally published in PROBLEMS AND SOLUTIONS OF SCIENTIFIC AND INNOVATIVE RESEARCH; Vol. 3 No. 1 (2026): PROBLEMS AND SOLUTIONS OF SCIENTIFIC AND INNOVATIVE RESEARCH; 11-13.

Rajabova, Nodira and Karimova, Nargiza (2026) THE TUMOR IMMUNE MICROENVIRONMENT AS A KEY DETERMINANT OF DISEASE PROGRESSION AND THERAPEUTIC RESPONSE IN HPV-ASSOCIATED CERVICAL CANCER. PROBLEMS AND SOLUTIONS OF SCIENTIFIC AND INNOVATIVE RESEARCH; Vol. 3 No. 1 (2026): PROBLEMS AND SOLUTIONS OF SCIENTIFIC AND INNOVATIVE RESEARCH; 11-13.

[thumbnail of 10218.pdf] PDF
10218.pdf - Published Version

Download (189kB)

Abstract

This thesis synthesizes current concepts of HPV-driven immune remodeling across disease stages, highlights TIME features associated with progression and outcome, and discusses actionable translational strategies—including biomarker-guided immunotherapy combinations, microenvironment reprogramming, and multi-omics profiling—to improve responses and durability of control.

Item Type: Article
Additional Information: Imported from Problems and Solutions of Scientific and Innovative Research
SWORD Depositor: Admin User
Depositing User: Admin User
Date Deposited: 28 Sep 2026 22:15
Last Modified: 28 Sep 2026 22:15
URI: https://universalpublishings.uz/id/eprint/16218

Actions (login required)

View Item
View Item